• Targeted prevention of road traffic deaths in Greece: a multifactorial 5-year census-based study 

  Anagnostou, E; Cole, E (2020-01-02)

• Comparison of cytokine and phosphoprotein profiles in idiopathic and Crohn's disease-related perianal fistula. 

  Haddow, JB; Musbahi, O; MacDonald, TT; Knowles, CH (Baishideng Publishing Group Inc., 2019-11-13)

  BACKGROUND: Perianal fistulae are either primary (idiopathic) or secondary [commonly associated with Crohn's disease, (CD)]. It is assumed, although not proven, that the pathophysiology differs. AIM: To systematically ...

• Continence technologies whitepaper: Informing new engineering science research 

  Culmer, P; Alazmani, A; Bryant, M; Mancuso, E; King, S; Mapunde, V; Jeays-Ward, K; Heron, N; Pearson, R; Vollebregt, PF (2019-01)

• Acute aorto-iliac and mesenteric arterial thromboses as presenting features of COVID-19 

  Vulliamy, P; Jacob, S; Davenport, RA (2020-05-15)

• Botox treatment in patients with chronic functional anorectal pain: experiences of a tertiary referral proctology clinic 

  Ooijevaar, RE; Felt-Bersma, RJF; Han-Geurts, IJ; van Reijn, D; Vollebregt, PF; Molenaar, CBH (2019-03)

• Bergamot essential oil and its constituent linalool, inhibit cholinergically-mediated contractions of human and rat isolated colon 

  Straface, M; Makwana, R; Rombola, L; Chinaleong, J; Morrone, LA; Sanger, GJ (Wiley, 2019-08-19)

  Meeting Abstract 154 from NeuroGASTRO 2019 Congress, 5‐7 September 2019, Lisbon, Portugal

• Patients with dyspepsia have impaired mucosal integrity both in the duodenum and jejunum: in vivo assessment of small bowel mucosal integrity using baseline impedance 

  Nakagawa, K; Hara, K; Fikree, A; Siddiqi, S; Woodland, P; Masamune, A; Aziz, Q; Sifrim, D; Yazaki, E (2020-03)

• CB1 antagonists SR141617A and AM251 stimulate insulin secretion from mouse and human islets 

  Ruz-Maldonado, I; Liu, B; Atanes, P; Pingitore, A; Huang, GC; Baker, D; Persaud, SJ (2018-03)

• Memory B Cells: Toward a Unified Therapeutic Target for Effective Immunotherapy in Multiple Sclerosis 

  Ceronie, B; Dubuisson, N; Ammoscato, F; Baker, D; Giovannoni, G; Schmierer, K (2018-04-10)

• MEMORY B CELLS ARE KEY FOR IMMUNOTHERAPY IN MULTIPLE SCLEROSIS 

  Schmierer, K; Marta, M; Pryce, G; Giovannoni, G; Baker, D (2017-12)

• SARS-CoV-2 and Multiple Sclerosis: Not all immune depleting DMTs are equal or bad. 

  Amor, S; Baker, D; Khoury, SJ; Schmierer, K; Giovanonni, G (Wiley Online, 2020-05-08)

  A major concern during the current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic1 is the use of immunosuppressive therapies for the treatment of multiple sclerosis (MS) due to an increased risk of ...

• The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic 

  Baker, D; Amor, S; Kang, AS; Schmierer, K; Giovannoni, G (Elsevier BV, 2020-08)

• Use of the Harmonic scalpel for Delorme's procedure 

  Pares, D; Drami, I; Adams, K; Grossi, U; Suliman, I; Knowles, CH (2017-06)

• Ultra-late recurrence of gastrointestinal stromal tumour: case report and literature review 

  Grossi, U; Ardito, F; Ciavarella, LP; Goglia, M; Giuliante, F (2019-05)

• Gatekeeper Improves Voluntary Contractility in Patients With Fecal Incontinence 

  Grossi, U; De Simone, V; Parello, A; Litta, F; Donisi, L; Luca Di Tanna, G; Goglia, M; Ratto, C (Sage Publications, 2018-12-14)

  Background. Gatekeeper (GK) has shown to be safe and effective in patients with fecal incontinence (FI). We aimed to understand its mechanism of action by comparing pre- and post-implant change in the external anal sphincter ...

• Contemporary surgical practice in the management of anal fistula: results from an international survey 

  Ratto, C; Grossi, U; Litta, F; Di Tanna, GL; Parello, A; De Simone, V; Tozer, P; De Zimmerman, D; Maeda, Y (2019-08)

• Recalled stapler device, high complication rate, non validated scoring system and misquote from the STARR surgeons 

  Grossi, U; Mercer-Jones, M; Di Tanna, GL; Knowles, CH (2019-10)

• Fistulotomy and primary sphincteroplasty for anal fistula: long-term data on continence and patient satisfaction. 

  Litta, F; Parello, A; De Simone, V; Grossi, U; Orefice, R; Ratto, C (Springer Nature Switzerland AG, 2019-09-19)

  BACKGROUND: The aim of this study was to evaluate the safety and long-term efficacy of fistulotomy and primary sphincteroplasty (FIPS). Secondary endpoints were its impact on postoperative continence status and patients' ...

• Sister Mary Joseph's nodule and colorectal cancer: an aggressive treatment for an aggressive disease. 

  Grossi, U; Petracca Ciavarella, L; Fuso, P; Crucitti, A (Wiley Online, 2019-11-28)

  A 60‐year‐old Caucasian man presented with a 6‐month history of pruritic erythematous umbilical papules, which rapidly worsened in 2 weeks to become ulcerated nodules (Fig. 1a). Serum tumour marker assay performed at the ...

• Effects of extracorporeal magnetic stimulation in fecal incontinence 

  Brusciano, L; Gambardella, C; Gualtieri, G; Terracciano, G; Tolone, S; Visconte, MSD; Grossi, U; Genio, GD; Docimo, L (De Gruyter, 2020-01-30)

  © 2020 Luigi Brusciano et al., published by De Gruyter. Fecal incontinence (FI) is a common condition that has devastating consequences for patients' QOL. In some patients, the conventional functional pelvic floor electrical ...

View more